Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The use of a tiny tool to pluck life-threatening blood clots out of arteries to the lungs resulted in a high patient survival rate, especially when compared to historical treatments such as blood ...

The intention-to-treat population comprised 544 patients: 273 in the intervention group and 271 in the control group. The mean (±SD) age was 58.2±13.5 years, and 42.6% of the patients were women. A ...

Patients who had low doses of clot-buster drugs delivered directly to the site of a pulmonary embolism (PE) via a catheter using ultrasound to enhance their effect had significantly better outcomes ...

Please provide your email address to receive an email when new articles are posted on . Two new thrombectomy devices showed good safety and efficacy in the treatment of intermediate-risk pulmonary ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

High-risk acute pulmonary embolism affects around 5% of all pulmonary embolisms and can take a dramatic course even in young people. Acute obstruction of the pulmonary circulation by a blood clot can ...